GSK3206641A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK3206641A, covering 2017-05-30 to 2023-10-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older [Phase 2]